This paper is in the following e-collection/theme issue:

New Methods (909) Human Factors and Usability Case Studies (747) Implantable Drug Delivery Systems, Ingestible Sensors and Digital Pills (14) HIV/AIDS/STI Prevention and Care (819)

Published on in Vol 22, No 7 (2020): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16904, first published .
Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study

Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study

Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study

Authors of this article:

Christine Tagliaferri Rael1 Author Orcid Image ;   Cody Lentz1 Author Orcid Image ;   Alex Carballo-Diéguez1 Author Orcid Image ;   Rebecca Giguere1 Author Orcid Image ;   Curtis Dolezal1 Author Orcid Image ;   Daniel Feller2 Author Orcid Image ;   Richard T D'Aquila3 Author Orcid Image ;   Thomas J Hope4, 5 Author Orcid Image
Article Authors Cited by (9) Tweetations (2) Metrics

Journals

  1. Chan C, Vaccher S, Fraser D, Grulich A, Holt M, Zablotska-Manos I, Prestage G, Bavinton B. Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia. AIDS and Behavior 2022;26(1):88 View
  2. Thoueille P, Choong E, Cavassini M, Buclin T, Decosterd L. Long-acting antiretrovirals: a new era for the management and prevention of HIV infection. Journal of Antimicrobial Chemotherapy 2022;77(2):290 View
  3. Sued O, Nardi N, Spadaccini L. Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review. Current Opinion in HIV and AIDS 2022;17(3):145 View
  4. Tagliaferri Rael C, Giguere R, Sutton S, Horn E, Schieffer R, Greene G, D'Aquila R, Bryndza Tfaily E, Kiser P, Hope T. Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice Study. AIDS Research and Human Retroviruses 2022;38(12):898 View
  5. Matthews R, Zang X, Barrett S, Koynov A, Goodey A, Heimbach T, Weissler V, Leyssens C, Reynders T, Xu Z, Rottey S, Vargo R, Robertson M, Stoch S, Iwamoto M. A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 2023;92(4):310 View
  6. Huang Y, Tian R, Zhou Z, Xu J, Agins B, Zou H, Chen Q, Sun Z, Zhong Q, Ma Z, Jiang H. HIV Pre-Exposure Prophylaxis Use on a Global Scale Among Men Who Have Sex with Men: A Systematic Review and Meta-Analysis. AIDS Patient Care and STDs 2023;37(4):159 View
  7. Vora L, Sabri A, Naser Y, Himawan A, Hutton A, Anjani Q, Volpe-Zanutto F, Mishra D, Li M, Rodgers A, Paredes A, Larrañeta E, Thakur R, Donnelly R. Long-acting microneedle formulations. Advanced Drug Delivery Reviews 2023;201:115055 View
  8. Rogers B, Chan P, Sutten-Coats C, Zanowick-Marr A, Patel R, Mena L, Goedel W, Chu C, Silva E, Galipeau D, Arnold T, Gomillia C, Curoe K, Villalobos J, Underwood A, Sosnowy C, Nunn A. Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the United States. BMC Public Health 2023;23(1) View
  9. Tagliaferri Rael C, Giguere R, Bryndza Tfaily E, Sutton S, Horn E, Schieffer R, Hendrix C, D’Aquila R, Hope T. The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men and Physicians. AIDS Research and Human Retroviruses 2024 View